IL6 and breast carcinoma: The identification of a feedback activation loop between IL-6 signaling and nuclear METTL3 function, which can be blunted by aspirin and nicotinamide co-treatment, unravels a critical interplay between inflammatory/oncogenic insults and RNA epigenetic state, which expedites breast cancer metastasis.